PetMed Express Elects New Directors
Ticker: PETS · Form: 8-K · Filed: Jun 24, 2024 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $50 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-of-directors, governance
Related Tickers: PETS
TL;DR
PetMed Express adds two new board members, Bingle and Briscoe, effective June 24, 2024.
AI Summary
PetMed Express, Inc. announced on June 24, 2024, a change in its board of directors. Specifically, the company elected two new directors, Michael J. Bingle and Robert L. Briscoe, to serve until the 2026 annual meeting of stockholders. This follows the resignation of director Michael J. Shribman.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting future performance and shareholder value.
Risk Assessment
Risk Level: low — The filing concerns routine board changes and does not involve significant financial transactions or operational disruptions.
Key Players & Entities
- PetMed Express, Inc. (company) — Registrant
- Michael J. Bingle (person) — Newly Elected Director
- Robert L. Briscoe (person) — Newly Elected Director
- Michael J. Shribman (person) — Resigned Director
- June 24, 2024 (date) — Date of Report
FAQ
Who were the newly elected directors at PetMed Express?
Michael J. Bingle and Robert L. Briscoe were elected as new directors.
When were the new directors elected?
The new directors were elected on June 24, 2024.
Until when will the newly elected directors serve?
They will serve until the 2026 annual meeting of stockholders.
Who resigned from the board of directors?
Michael J. Shribman resigned from the board of directors.
What is the principal executive office address for PetMed Express?
The principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.
Filing Stats: 1,143 words · 5 min read · ~4 pages · Grade level 10 · Accepted 2024-06-24 08:09:39
Key Financial Figures
- $50 million — ght years, Ms. Solivan raised more than $50 million in venture capital and scaled the compa
Filing Documents
- pets-20240624.htm (8-K) — 33KB
- pets-20240624xexx991pressr.htm (EX-99.1) — 11KB
- 0001040130-24-000048.txt ( ) — 171KB
- pets-20240624.xsd (EX-101.SCH) — 2KB
- pets-20240624_lab.xml (EX-101.LAB) — 21KB
- pets-20240624_pre.xml (EX-101.PRE) — 12KB
- pets-20240624_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On June 24, 2024, the Company issued a press release announcing the appointment of Ms. Solivan as a member of the Board. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01 and the related information in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act or the Exchange Act except as set forth by specific reference in such filing. 2
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated June 2 4 , 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL) * * * 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 24, 2024 PETMED EXPRESS, INC. By: /s/ Christine Chambers Name: Christine Chambers Title: Chief Financial Officer, Treasurer and Secretary 4